These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28351590)

  • 1. Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
    Dong G; Fang Y; Liu Y; Liu N; Wu S; Zhang W; Sheng C
    Bioorg Med Chem Lett; 2017 May; 27(9):1929-1933. PubMed ID: 28351590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions.
    Kardile RA; Sarkate AP; Borude AS; Mane RS; Lokwani DK; Tiwari SV; Azad R; Burra PVLS; Thopate SR
    Bioorg Chem; 2021 Oct; 115():105174. PubMed ID: 34314913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons.
    Ahmed EM; Khalil NA; Zaher AF; Alhamaky SM; El-Zoghbi MS
    Bioorg Chem; 2021 Jul; 112():104915. PubMed ID: 33905973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.
    Martín-Encinas E; Rubiales G; Knudsen BR; Palacios F; Alonso C
    Bioorg Med Chem; 2021 Jun; 40():116177. PubMed ID: 33962152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.
    Seol Y; Zhang H; Agama K; Lorence N; Pommier Y; Neuman KC
    Mol Cancer Ther; 2015 Nov; 14(11):2552-9. PubMed ID: 26351326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Synthesis of Chlorinated and Fluorinated 7-Azaindenoisoquinolines as Potent Cytotoxic Anticancer Agents That Inhibit Topoisomerase I.
    Elsayed MSA; Su Y; Wang P; Sethi T; Agama K; Ravji A; Redon CE; Kiselev E; Horzmann KA; Freeman JL; Pommier Y; Cushman M
    J Med Chem; 2017 Jul; 60(13):5364-5376. PubMed ID: 28657311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
    Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
    Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies.
    Zeng H; Zhang S; Nie H; Li J; Yang J; Zhuang Y; Huang Y; Zeng M
    Bioorg Chem; 2024 Jun; 147():107412. PubMed ID: 38696845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.
    Elbadawi MM; Eldehna WM; Wang W; Agama KK; Pommier Y; Abe M
    Eur J Med Chem; 2021 Apr; 215():113261. PubMed ID: 33631697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison.
    Chen YX; Wu S; Shen X; Xu DF; Wang Q; Ji SH; Zhu H; Wu G; Sheng C; Cai YR
    Chemistry; 2024 Jul; 30(39):e202401400. PubMed ID: 38736421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,7-bis-benzylidene hydrazide ciprofloxacin derivatives as promising antiproliferative dual TOP I & TOP II isomerases inhibitors.
    Samir M; Ramadan M; Abdelrahman MH; Abdelbaset MS; Abourehab MAS; Abdel-Aziz M; Abuo-Rahma GEA
    Bioorg Chem; 2021 May; 110():104698. PubMed ID: 33676043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Anticancer Activity of Thiadiazole Containing Thiourea, Benzothiazole and Imidazo[2,1-b][1,3,4]thiadiazole Scaffolds.
    Avvaru SP; Noolvi MN; More UA; Chakraborty S; Dash A; Aminabhavi TM; Narayan KP; Sutariya V
    Med Chem; 2021; 17(7):750-765. PubMed ID: 32427086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.
    Nguyen TX; Abdelmalak M; Marchand C; Agama K; Pommier Y; Cushman M
    J Med Chem; 2015 Apr; 58(7):3188-208. PubMed ID: 25811317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New N-(1,3,4-thiadiazol-2-yl)furan-2-carboxamide derivatives as potential inhibitors of the VEGFR-2.
    Hekal MH; Farag PS; Hemdan MM; El-Sayed WM
    Bioorg Chem; 2021 Oct; 115():105176. PubMed ID: 34303038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and correlation of cytotoxicity versus redox potential of 1,4-naphthoquinone derivatives.
    Shen CC; Afraj SN; Hung CC; Barve BD; Kuo LY; Lin ZH; Ho HO; Kuo YH
    Bioorg Med Chem Lett; 2021 Jun; 41():127976. PubMed ID: 33766765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation.
    Kiselev E; Empey N; Agama K; Pommier Y; Cushman M
    J Org Chem; 2012 Jun; 77(11):5167-72. PubMed ID: 22587603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.
    Wu N; Wu XW; Agama K; Pommier Y; Du J; Li D; Gu LQ; Huang ZS; An LK
    Biochemistry; 2010 Nov; 49(47):10131-6. PubMed ID: 21033700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 4-nitroimidazole analogues: synthesis,
    Al-Soud YA; Al-Sawakhnah SO; Al-Qawasmeh RA; Al-Masoudi NA; Al-Ahmad AH; Al-Maliki L; van Geelen L; Kalscheuer R; Saeed BA; Shtaiwi A; Stark H
    Z Naturforsch C J Biosci; 2024 Mar; 79(3-4):61-71. PubMed ID: 38578162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor.
    Yu Q; Chen Y; Yang H; Zhang HL; Agama K; Pommier Y; An LK
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):818-822. PubMed ID: 30907213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase I inhibitors: Challenges, progress and the road ahead.
    Talukdar A; Kundu B; Sarkar D; Goon S; Mondal MA
    Eur J Med Chem; 2022 Jun; 236():114304. PubMed ID: 35413618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.